Role of hepcidin upregulation and proteolytic cleavage of ferroportin 1 in hepatitis C virus-induced iron accumulation
暂无分享,去创建一个
Hirotaka Takahashi | T. Sawasaki | Satoshi Sakai | Tetsuro Suzuki | T. Suda | I. Shoji | Y. Kanegae | K. Nakashima | Takeshi Chida | H. Kawasaki | K. Kawata | S. Takabayashi | Kazuyoshi Ohta | T. Aoshima | Masahiko Ito | Shuji Takabayashi
[1] N. Luhmann,et al. New WHO guidance for country validation of viral hepatitis B and C elimination. , 2021, The lancet. Gastroenterology & hepatology.
[2] Irum Rehman,et al. Correlation Between Serum Ferritin and Hepcidin Levels in Chronic Hepatitis C Patients , 2021, Cureus.
[3] K. Shinmura,et al. Diagnosis of Ion-Exchange Resin Depositions in Paraffin Sections Using Corrective Light and Electron Microscopy-NanoSuit Method , 2021, Diagnostics.
[4] F. Penin,et al. OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A protease , 2020, PloS one.
[5] R. Dror,et al. Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms , 2020, Nature.
[6] B. Lindenbach,et al. Hepatitis C virus NS3-4A protease regulates the lipid environment for RNA replication by cleaving host enzyme 24-dehydrocholesterol reductase , 2020, The Journal of Biological Chemistry.
[7] H. Sugimura,et al. Utility of Scanning Electron Microscopy Elemental Analysis Using the ‘NanoSuit’ Correlative Light and Electron Microscopy Method in the Diagnosis of Lanthanum Phosphate Deposition in the Esophagogastroduodenal Mucosa , 2019, Diagnostics.
[8] Liyun Shi,et al. Reduced expression of ferroportin1 and ceruloplasmin predicts poor prognosis in adrenocortical carcinoma. , 2019, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[9] Y. Takaku,et al. The NanoSuit method: a novel histological approach for examining paraffin sections in a nondestructive manner by correlative light and electron microscopy , 2019, Laboratory Investigation.
[10] C. Webber,et al. Antiviral activity of bone morphogenetic proteins and activins , 2018, Nature Microbiology.
[11] R. Flisiak,et al. Normalizing serum hepcidin but not α-1-antitrypsin level during effective treatment of chronic hepatitis C , 2017, Clinical and experimental hepatology.
[12] Masahiro Yamamoto,et al. Critical role of CREBH‐mediated induction of transforming growth factor β2 by hepatitis C virus infection in fibrogenic responses in hepatic stellate cells , 2017, Hepatology.
[13] O. Nureki,et al. Outward- and inward-facing structures of a putative bacterial transition-metal transporter with homology to ferroportin , 2015, Nature Communications.
[14] Xiaozhou He,et al. Decreased expression of ferroportin in prostate cancer. , 2015, Oncology letters.
[15] F. Zhan,et al. Decreased ferroportin promotes myeloma cell growth and osteoclast differentiation. , 2015, Cancer research.
[16] K. Bielawski,et al. Association of Hepcidin mRNA Expression With Hepatocyte Iron Accumulation and Effects of Antiviral Therapy in Chronic Hepatitis C Infection , 2014, Hepatitis monthly.
[17] Zhigang Zhang,et al. Duodenal Ferroportin Is Up-Regulated in Patients with Chronic Hepatitis C , 2014, PloS one.
[18] W. Hörl,et al. Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[19] Céline Hernandez,et al. Quantitative proteomics identifies the membrane‐associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3‐4A protease , 2014, Hepatology.
[20] C. Fillebeen,et al. Hepatitis C Virus Infection Causes Iron Deficiency in Huh7.5.1 Cells , 2013, PloS one.
[21] A. Ido,et al. Hepatitis C Virus NS3/4A Protease Inhibits Complement Activation by Cleaving Complement Component 4 , 2013, PloS one.
[22] Y. Kanegae,et al. Efficient production of adenovirus vector lacking genes of virus-associated RNAs that disturb cellular RNAi machinery , 2013, Scientific Reports.
[23] Xi Chen,et al. DDB1 is a cellular substrate of NS3/4A protease and required for hepatitis C virus replication. , 2013, Virology.
[24] J. Doudna,et al. A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.
[25] P. Schirmacher,et al. Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response. , 2012, Gastroenterology.
[26] Y. Kanegae,et al. Copy number of adenoviral vector genome transduced into target cells can be measured using quantitative PCR: application to vector titration. , 2012, Biochemical and biophysical research communications.
[27] J. Wands,et al. Hepatitis C virus NS2 protein triggers endoplasmic reticulum stress and suppresses its own viral replication. , 2010, Journal of hepatology.
[28] E. Tsochatzis,et al. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C , 2010, Journal of viral hepatitis.
[29] K. Ishii,et al. Production of Infectious Hepatitis C Virus by Using RNA Polymerase I-Mediated Transcription , 2010, Journal of Virology.
[30] R. Purcell,et al. Novel Infectious cDNA Clones of Hepatitis C Virus Genotype 3a (Strain S52) and 4a (Strain ED43): Genetic Analyses and In Vivo Pathogenesis Studies , 2010, Journal of Virology.
[31] D. Girelli,et al. Reduced serum hepcidin levels in patients with chronic hepatitis C. , 2009, Journal of hepatology.
[32] R. Kaufman,et al. ER Stress Controls Iron Metabolism Through Induction of Hepcidin , 2009, Science.
[33] R. Bartenschlager,et al. Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor–induced signal transduction by cleavage of the T‐cell protein tyrosine phosphatase , 2009, Hepatology.
[34] D. Brenner,et al. Hepatitis C virus–induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity , 2008, Hepatology.
[35] Jennifer L Luebke-Wheeler,et al. Hepatocyte nuclear factor 4α is implicated in endoplasmic reticulum stress–induced acute phase response by regulating expression of cyclic adenosine monophosphate responsive element binding protein H , 2008, Hepatology.
[36] N. Tomosugi,et al. Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma , 2008, BMC Cancer.
[37] M. Kanaoka,et al. Expression of pIX gene induced by transgene promoter: possible cause of host immune response in first-generation adenoviral vectors. , 2007, Human gene therapy.
[38] Yin Xia,et al. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. , 2007, The Journal of clinical investigation.
[39] N. Andrews,et al. Interleukin-6 induces hepcidin expression through STAT3. , 2006, Blood.
[40] F. Chisari,et al. Production of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived Cells , 2006, Journal of Virology.
[41] Randal J. Kaufman,et al. Endoplasmic Reticulum Stress Activates Cleavage of CREBH to Induce a Systemic Inflammatory Response , 2006, Cell.
[42] Zhijian J. Chen,et al. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[43] Xiaoling Xu,et al. A Role of Smad4 in Iron Metabolism through the Positive Regulation of Hepcidin Expression , 2022 .
[44] Ralf Bartenschlager,et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.
[45] Toshiaki Maruyama,et al. Complete Replication of Hepatitis C Virus in Cell Culture , 2005, Science.
[46] D. Burton,et al. Robust hepatitis C virus infection in vitro. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[47] J. Ferreon,et al. Molecular Determinants of TRIF Proteolysis Mediated by the Hepatitis C Virus NS3/4A Protease* , 2005, Journal of Biological Chemistry.
[48] Stanley M Lemon,et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[49] R. Hultcrantz,et al. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. , 2003, Gastroenterology.
[50] Ying E. Zhang,et al. Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.
[51] Stanley M. Lemon,et al. Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease , 2003, Science.
[52] Elizabeta Nemeth,et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. , 2003, Blood.
[53] M. Salah,et al. Methodology , 2003 .
[54] M. Mattioli,et al. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non–iron‐related chronic liver disease , 2001, Hepatology.
[55] R. Kirsch,et al. Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. , 1996, Journal of hepatology.
[56] P. Brissot,et al. Differentiation Between Heterozygotes and Homozygotes in Genetic Hemochromatosis by Means of a Histological Hepatic Iron Index: A Study of 192 Cases , 1993, Hepatology.
[57] Y. Nan,et al. A correlation analysis of the serum hepcidin concentrations and viral loads in HCV-infected patients. , 2021, American journal of translational research.
[58] Xi Chen,et al. DDB 1 is a cellular substrate of NS 3 / 4 A protease and required for hepatitis C virus replication , 2012 .
[59] K. Okita,et al. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. , 2008, Gastroenterology.
[60] M. Kaito,et al. Hepcidin Expression in the Liver: Relatively Low Level in Patients with Chronic Hepatitis C , 2007, Molecular medicine.
[61] M. Wessling-Resnick,et al. Iron imports. III. Transfer of iron from the mucosa into circulation. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[62] R. Derynck,et al. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.